Literature DB >> 32486848

Histone deacetylase-3: Friend and foe of the brain.

Santosh R D'Mello1.   

Abstract

IMPACT STATEMENT: Brain development and degeneration are highly complex processes that are regulated by a large number of molecules and signaling pathways the identities of which are being unraveled. Accumulating evidence points to histone deacetylases and epigenetic mechanisms as being important regulators of these processes. In this review, we describe that histone deacetylase-3 (HDAC3) is a particularly crucial regulator of both neurodevelopment and neurodegeneration. In addition, HDAC3 regulates memory formation, synaptic plasticity, and the cognitive impairment associated with normal aging. Understanding how HDAC3 functions contributes to the normal development and functioning of the brain while also promoting neurodegeneration could lead to the development of therapeutic approaches for neurodevelopmental, neuropsychiatric, and neurodegenerative disorders.

Entities:  

Keywords:  Histone deacetylases; aging; histone deacetylase-3; learning and memory; neurodegenerative diseases; neurodevelopment

Mesh:

Substances:

Year:  2020        PMID: 32486848      PMCID: PMC7400723          DOI: 10.1177/1535370220928278

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  157 in total

Review 1.  Histone modifications in transcriptional regulation.

Authors:  Shelley L Berger
Journal:  Curr Opin Genet Dev       Date:  2002-04       Impact factor: 5.578

2.  Genetic deletion of neuronal pentraxin 1 expression prevents brain injury in a neonatal mouse model of cerebral hypoxia-ischemia.

Authors:  Shabarish Thatipamula; Md Al Rahim; Jiangyang Zhang; Mir Ahamed Hossain
Journal:  Neurobiol Dis       Date:  2014-12-29       Impact factor: 5.996

3.  Ataxin-3 represses transcription via chromatin binding, interaction with histone deacetylase 3, and histone deacetylation.

Authors:  Bernd O Evert; Julieta Araujo; Ana M Vieira-Saecker; Rob A I de Vos; Sigrid Harendza; Thomas Klockgether; Ullrich Wüllner
Journal:  J Neurosci       Date:  2006-11-01       Impact factor: 6.167

Review 4.  Epigenetics in Neurodegenerative Diseases: The Role of Histone Deacetylases.

Authors:  Sorabh Sharma; K C Sarathlal; Rajeev Taliyan
Journal:  CNS Neurol Disord Drug Targets       Date:  2019       Impact factor: 4.388

5.  Histone deacetylase-1 (HDAC1) is a molecular switch between neuronal survival and death.

Authors:  Farah H Bardai; Valerie Price; Marcus Zaayman; Lulu Wang; Santosh R D'Mello
Journal:  J Biol Chem       Date:  2012-08-23       Impact factor: 5.157

6.  Dysbindin-1, a schizophrenia-related protein, interacts with HDAC3.

Authors:  Mika Soma; Min Wang; Satoshi Suo; Shoichi Ishiura
Journal:  Neurosci Lett       Date:  2014-09-06       Impact factor: 3.046

7.  Characterization of transcriptional regulatory domains of ankyrin repeat cofactor-1.

Authors:  Aihua Zhang; Chia-Wei Li; J Don Chen
Journal:  Biochem Biophys Res Commun       Date:  2007-05-11       Impact factor: 3.575

Review 8.  GSK-3β, a pivotal kinase in Alzheimer disease.

Authors:  María Llorens-Martín; Jerónimo Jurado; Félix Hernández; Jesús Avila
Journal:  Front Mol Neurosci       Date:  2014-05-21       Impact factor: 5.639

9.  Genetic deletion of NP1 prevents hypoxic-ischemic neuronal death via reducing AMPA receptor synaptic localization in hippocampal neurons.

Authors:  Md Al Rahim; Mir Ahamed Hossain
Journal:  J Am Heart Assoc       Date:  2013-02-22       Impact factor: 5.501

10.  Inhibition of HDAC3 reverses Alzheimer's disease-related pathologies in vitro and in the 3xTg-AD mouse model.

Authors:  Karolina J Janczura; Claude-Henry Volmar; Gregory C Sartor; Sunil J Rao; Natalie R Ricciardi; Guerline Lambert; Shaun P Brothers; Claes Wahlestedt
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-05       Impact factor: 11.205

View more
  2 in total

Review 1.  Recent Advances in Epigenetics of Age-Related Kidney Diseases.

Authors:  Feng Liu; Jiefang Chen; Zhenqiong Li; Xianfang Meng
Journal:  Genes (Basel)       Date:  2022-04-29       Impact factor: 4.141

Review 2.  When Good Kinases Go Rogue: GSK3, p38 MAPK and CDKs as Therapeutic Targets for Alzheimer's and Huntington's Disease.

Authors:  Santosh R D'Mello
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.